Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

By Nussenblatt R.B.   Thompson D.J.S.   Li Z.   Peterson J.S.   Robinson R.R.   Shames R.S.   Nagarajan S.   Tang M.T.   Mailman M.   Velez G.   Roy C.   Levy-Clarke G.A.   Suhler E.B.   Djalilian A.   Sen H.N.   Al-Khatib S.   Ursea R.   Srivastava S.   Bamji A.   Mellow S.   Sran P.   Waldmann T.A.   Buggage R.R.  

Journal of Autoimmunity, Vol. 21, Iss. 3, 2003-11 ,pp. : 283-293

Elsevier

Access to resources Recommend Favorite

Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens

By Vincenti F.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3169-3171

Elsevier

Access to resources Recommend Favorite

Immunosuppression with calcineurin inhibitors and polyclonal antibodies in liver transplantation

By Rafecas A.   Llado L.   Albiol M.T.   Ramos E.   Torras J.   Fabregat J.   Lama C.   Busquets J.   Ibanez L.   Figueras J.   Jaurrieta E.  

Transplantation Proceedings, Vol. 34, Iss. 1, 2002-02 ,pp. : 107-107

Elsevier

Access to resources Recommend Favorite

A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: long-term results

By Baldi A.   Malaise J.   Mourad M.   Squifflet J.P.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 429-431

Elsevier

Access to resources Recommend Favorite

Role of Idiotype-Independent Anti-IgG Autoantibodies in Human Kidney Transplantation: Natural Anti-F(ab')2 Antibodies Recognize an IgG1 Hinge Region Epitope

By Terness P.   Navolan D.   Kohl I.   Siedler F.   Moroder L.   Dufter C.   Welschof M.   Schneider F.   Drugarin D.   Opelz G.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1412-1414

Elsevier

Access to resources Recommend Favorite